 Wendy Tzou
Concepts (330)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 80 | 2025 | 336 | 17.020 |
Why?
| | Tachycardia, Ventricular | 47 | 2025 | 168 | 12.160 |
Why?
| | Atrial Fibrillation | 25 | 2025 | 376 | 6.890 |
Why?
| | Cardiomyopathies | 18 | 2025 | 340 | 3.820 |
Why?
| | Arrhythmias, Cardiac | 23 | 2024 | 322 | 2.890 |
Why?
| | Electrophysiologic Techniques, Cardiac | 19 | 2024 | 79 | 2.710 |
Why?
| | Cicatrix | 6 | 2022 | 63 | 2.200 |
Why?
| | Transcatheter Aortic Valve Replacement | 5 | 2023 | 121 | 2.140 |
Why?
| | Ventricular Premature Complexes | 9 | 2025 | 36 | 2.030 |
Why?
| | Electrocardiography | 21 | 2025 | 613 | 1.800 |
Why?
| | Heart Ventricles | 13 | 2025 | 781 | 1.760 |
Why?
| | Defibrillators, Implantable | 15 | 2023 | 300 | 1.730 |
Why?
| | Heart Diseases | 6 | 2023 | 352 | 1.630 |
Why?
| | Pacemaker, Artificial | 5 | 2023 | 111 | 1.560 |
Why?
| | Cardiac Electrophysiology | 11 | 2024 | 18 | 1.490 |
Why?
| | Heart Block | 4 | 2024 | 40 | 1.430 |
Why?
| | Pericardium | 9 | 2021 | 54 | 1.410 |
Why?
| | Atrioventricular Block | 2 | 2021 | 35 | 1.330 |
Why?
| | Aortic Valve Stenosis | 4 | 2023 | 219 | 1.300 |
Why?
| | Amiodarone | 2 | 2021 | 25 | 1.270 |
Why?
| | Cardiac Pacing, Artificial | 5 | 2023 | 86 | 1.230 |
Why?
| | Pulmonary Veins | 3 | 2019 | 98 | 1.220 |
Why?
| | Heart Failure | 7 | 2024 | 2148 | 1.120 |
Why?
| | Death, Sudden, Cardiac | 6 | 2025 | 179 | 1.070 |
Why?
| | Heart Conduction System | 11 | 2024 | 95 | 1.060 |
Why?
| | Atrial Appendage | 3 | 2022 | 15 | 1.030 |
Why?
| | Treatment Outcome | 40 | 2025 | 10241 | 0.970 |
Why?
| | Myocardium | 12 | 2023 | 983 | 0.970 |
Why?
| | Humans | 122 | 2025 | 129847 | 0.970 |
Why?
| | Echocardiography | 7 | 2025 | 636 | 0.920 |
Why?
| | Electric Countershock | 6 | 2023 | 105 | 0.880 |
Why?
| | Neuromuscular Diseases | 2 | 2024 | 105 | 0.870 |
Why?
| | Anti-Arrhythmia Agents | 9 | 2024 | 112 | 0.860 |
Why?
| | Recurrence | 16 | 2024 | 1013 | 0.850 |
Why?
| | Muscular Dystrophies | 1 | 2023 | 35 | 0.830 |
Why?
| | Electrocardiography, Ambulatory | 3 | 2019 | 58 | 0.820 |
Why?
| | Endocardium | 7 | 2022 | 33 | 0.810 |
Why?
| | Electrodes | 6 | 2022 | 105 | 0.770 |
Why?
| | Myocarditis | 1 | 2023 | 98 | 0.770 |
Why?
| | Pericardial Effusion | 2 | 2022 | 21 | 0.750 |
Why?
| | Heart Atria | 7 | 2025 | 129 | 0.730 |
Why?
| | Carotid Arteries | 4 | 2006 | 196 | 0.730 |
Why?
| | Postoperative Complications | 7 | 2019 | 2481 | 0.700 |
Why?
| | Surgery, Computer-Assisted | 1 | 2021 | 77 | 0.680 |
Why?
| | Esophagus | 3 | 2023 | 251 | 0.660 |
Why?
| | Ablation Techniques | 2 | 2019 | 35 | 0.650 |
Why?
| | Cardiology | 5 | 2020 | 266 | 0.650 |
Why?
| | Consensus | 11 | 2020 | 622 | 0.640 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2022 | 381 | 0.620 |
Why?
| | Tunica Intima | 4 | 2008 | 84 | 0.580 |
Why?
| | Aged | 40 | 2025 | 22107 | 0.570 |
Why?
| | Risk Factors | 21 | 2025 | 9801 | 0.570 |
Why?
| | Middle Aged | 49 | 2025 | 31177 | 0.550 |
Why?
| | Heart Rate | 6 | 2019 | 804 | 0.550 |
Why?
| | Action Potentials | 7 | 2019 | 485 | 0.530 |
Why?
| | Epicardial Mapping | 5 | 2022 | 5 | 0.520 |
Why?
| | Cardiac Resynchronization Therapy | 1 | 2017 | 45 | 0.510 |
Why?
| | Tachycardia, Supraventricular | 2 | 2021 | 44 | 0.490 |
Why?
| | Cardiac Catheters | 4 | 2020 | 15 | 0.490 |
Why?
| | Therapeutic Irrigation | 4 | 2020 | 78 | 0.490 |
Why?
| | Atrial Flutter | 3 | 2024 | 35 | 0.480 |
Why?
| | Male | 59 | 2025 | 63759 | 0.470 |
Why?
| | Venous Thrombosis | 1 | 2017 | 176 | 0.470 |
Why?
| | Risk Assessment | 14 | 2024 | 3269 | 0.470 |
Why?
| | Arthritis, Rheumatoid | 1 | 2023 | 1098 | 0.450 |
Why?
| | Body Temperature | 3 | 2015 | 214 | 0.450 |
Why?
| | Catheters | 4 | 2022 | 70 | 0.440 |
Why?
| | Sarcoidosis | 3 | 2024 | 157 | 0.440 |
Why?
| | Multimodal Imaging | 3 | 2019 | 110 | 0.430 |
Why?
| | Female | 57 | 2025 | 68829 | 0.430 |
Why?
| | Registries | 7 | 2025 | 1903 | 0.420 |
Why?
| | Societies, Medical | 5 | 2020 | 759 | 0.420 |
Why?
| | Bundle-Branch Block | 3 | 2023 | 31 | 0.420 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2013 | 21 | 0.420 |
Why?
| | Aortic Valve | 4 | 2023 | 348 | 0.410 |
Why?
| | Time Factors | 13 | 2025 | 6550 | 0.410 |
Why?
| | Heart | 6 | 2022 | 645 | 0.380 |
Why?
| | Atrioventricular Node | 2 | 2021 | 15 | 0.370 |
Why?
| | Predictive Value of Tests | 8 | 2019 | 1951 | 0.370 |
Why?
| | Swine | 7 | 2023 | 761 | 0.370 |
Why?
| | Retrospective Studies | 26 | 2025 | 14553 | 0.360 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 2 | 2021 | 30 | 0.350 |
Why?
| | Incidence | 7 | 2021 | 2646 | 0.340 |
Why?
| | Stroke Volume | 9 | 2025 | 593 | 0.340 |
Why?
| | Heart Valve Prosthesis | 2 | 2025 | 113 | 0.340 |
Why?
| | Cattle | 12 | 2020 | 978 | 0.330 |
Why?
| | Carotid Artery Diseases | 2 | 2008 | 64 | 0.330 |
Why?
| | Tunica Media | 3 | 2008 | 38 | 0.330 |
Why?
| | Ventricular Fibrillation | 2 | 2025 | 57 | 0.330 |
Why?
| | Cardiac Catheterization | 2 | 2022 | 520 | 0.320 |
Why?
| | Ventricular Dysfunction, Left | 4 | 2025 | 385 | 0.310 |
Why?
| | Ventricular Function, Left | 5 | 2021 | 529 | 0.310 |
Why?
| | Ultrasonography | 3 | 2008 | 713 | 0.310 |
Why?
| | Follow-Up Studies | 13 | 2024 | 4896 | 0.290 |
Why?
| | Cardiac Surgical Procedures | 3 | 2021 | 509 | 0.280 |
Why?
| | Survival Rate | 5 | 2019 | 1872 | 0.280 |
Why?
| | Decision Support Techniques | 2 | 2022 | 401 | 0.280 |
Why?
| | Reoperation | 3 | 2019 | 542 | 0.270 |
Why?
| | Body Surface Potential Mapping | 5 | 2019 | 8 | 0.270 |
Why?
| | Hypercapnia | 1 | 2007 | 50 | 0.270 |
Why?
| | Coronary Circulation | 1 | 2007 | 139 | 0.260 |
Why?
| | Genetic Testing | 1 | 2009 | 422 | 0.260 |
Why?
| | Bradycardia | 2 | 2024 | 53 | 0.260 |
Why?
| | Cardiac Imaging Techniques | 2 | 2019 | 20 | 0.250 |
Why?
| | Adult | 25 | 2025 | 35634 | 0.250 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2024 | 1368 | 0.240 |
Why?
| | Blood Flow Velocity | 1 | 2007 | 406 | 0.240 |
Why?
| | Arteriosclerosis | 1 | 2005 | 89 | 0.240 |
Why?
| | Mitral Valve Prolapse | 1 | 2025 | 9 | 0.240 |
Why?
| | Coronary Vessels | 1 | 2007 | 239 | 0.240 |
Why?
| | Bundle of His | 2 | 2023 | 17 | 0.230 |
Why?
| | Point-of-Care Systems | 1 | 2006 | 149 | 0.230 |
Why?
| | Hot Temperature | 3 | 2023 | 369 | 0.230 |
Why?
| | Patient Discharge | 2 | 2025 | 856 | 0.220 |
Why?
| | Accessory Atrioventricular Bundle | 2 | 2021 | 13 | 0.220 |
Why?
| | Syncope, Vasovagal | 1 | 2024 | 5 | 0.220 |
Why?
| | Amyloidosis | 1 | 2024 | 42 | 0.220 |
Why?
| | Reproducibility of Results | 6 | 2019 | 3089 | 0.220 |
Why?
| | Liposomes | 2 | 2023 | 171 | 0.220 |
Why?
| | Cholesterol | 1 | 2005 | 412 | 0.210 |
Why?
| | Rheumatic Diseases | 1 | 2024 | 69 | 0.210 |
Why?
| | Physicians, Women | 1 | 2024 | 72 | 0.210 |
Why?
| | Multicenter Studies as Topic | 2 | 2024 | 287 | 0.210 |
Why?
| | Biophysical Phenomena | 2 | 2020 | 64 | 0.210 |
Why?
| | Prospective Studies | 7 | 2024 | 7158 | 0.200 |
Why?
| | Temperature | 2 | 2023 | 635 | 0.200 |
Why?
| | Animals | 17 | 2023 | 35409 | 0.190 |
Why?
| | Metabolic Syndrome | 1 | 2005 | 340 | 0.190 |
Why?
| | Thromboembolism | 1 | 2023 | 112 | 0.190 |
Why?
| | Philadelphia | 3 | 2019 | 47 | 0.180 |
Why?
| | Pre-Excitation Syndromes | 1 | 2021 | 5 | 0.180 |
Why?
| | Glycogen Storage Disease Type IIb | 1 | 2021 | 25 | 0.180 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 2 | 2012 | 39 | 0.180 |
Why?
| | Patient Reported Outcome Measures | 1 | 2024 | 374 | 0.180 |
Why?
| | Skin | 1 | 2005 | 725 | 0.180 |
Why?
| | Coronary Sinus | 1 | 2020 | 7 | 0.170 |
Why?
| | United States | 11 | 2025 | 13913 | 0.170 |
Why?
| | Anticoagulants | 3 | 2023 | 637 | 0.160 |
Why?
| | Prevalence | 5 | 2021 | 2564 | 0.160 |
Why?
| | Papillary Muscles | 1 | 2019 | 14 | 0.160 |
Why?
| | Length of Stay | 1 | 2025 | 1133 | 0.160 |
Why?
| | Prognosis | 7 | 2019 | 3773 | 0.160 |
Why?
| | Heart-Assist Devices | 2 | 2023 | 538 | 0.160 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2019 | 24 | 0.160 |
Why?
| | Patient Safety | 2 | 2020 | 291 | 0.160 |
Why?
| | Aortic Valve Insufficiency | 1 | 2019 | 46 | 0.160 |
Why?
| | Colorado | 3 | 2019 | 4410 | 0.150 |
Why?
| | Esophageal Fistula | 1 | 2019 | 19 | 0.150 |
Why?
| | Mitral Valve Insufficiency | 1 | 2019 | 67 | 0.150 |
Why?
| | Kaplan-Meier Estimate | 4 | 2018 | 851 | 0.150 |
Why?
| | In Vitro Techniques | 5 | 2020 | 1092 | 0.150 |
Why?
| | Heparin | 1 | 2020 | 254 | 0.150 |
Why?
| | Hypertension | 2 | 2017 | 1242 | 0.150 |
Why?
| | Fibrosis | 2 | 2018 | 526 | 0.140 |
Why?
| | Medicare | 3 | 2022 | 719 | 0.140 |
Why?
| | Ventricular Function, Right | 1 | 2019 | 276 | 0.130 |
Why?
| | Materials Testing | 2 | 2016 | 349 | 0.130 |
Why?
| | Antihypertensive Agents | 2 | 2017 | 485 | 0.130 |
Why?
| | Environment | 1 | 2018 | 345 | 0.130 |
Why?
| | Echocardiography, Transesophageal | 1 | 2017 | 93 | 0.130 |
Why?
| | Magnets | 1 | 2016 | 18 | 0.130 |
Why?
| | Disease Management | 1 | 2020 | 592 | 0.130 |
Why?
| | Heart Injuries | 1 | 2016 | 37 | 0.120 |
Why?
| | Adipose Tissue | 1 | 2020 | 594 | 0.120 |
Why?
| | Ferric Compounds | 1 | 2016 | 46 | 0.120 |
Why?
| | Mitral Valve | 2 | 2019 | 86 | 0.120 |
Why?
| | Equipment Design | 4 | 2020 | 514 | 0.120 |
Why?
| | Thermography | 1 | 2015 | 11 | 0.120 |
Why?
| | Metal Nanoparticles | 1 | 2016 | 81 | 0.120 |
Why?
| | Blood Coagulation | 1 | 2017 | 239 | 0.120 |
Why?
| | Odds Ratio | 2 | 2010 | 1022 | 0.120 |
Why?
| | Adiposity | 1 | 2020 | 504 | 0.120 |
Why?
| | Heart Transplantation | 1 | 2020 | 722 | 0.110 |
Why?
| | Nanotubes, Carbon | 1 | 2014 | 40 | 0.110 |
Why?
| | Stroke | 1 | 2022 | 1072 | 0.110 |
Why?
| | Medical Records | 1 | 2015 | 171 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 4 | 2025 | 3397 | 0.110 |
Why?
| | Fee-for-Service Plans | 1 | 2014 | 88 | 0.110 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2013 | 28 | 0.110 |
Why?
| | Feasibility Studies | 2 | 2015 | 870 | 0.110 |
Why?
| | Energy Transfer | 1 | 2013 | 47 | 0.110 |
Why?
| | Systole | 2 | 2019 | 191 | 0.100 |
Why?
| | Primary Prevention | 1 | 2014 | 190 | 0.100 |
Why?
| | Hemodynamics | 1 | 2017 | 1094 | 0.100 |
Why?
| | Sinus of Valsalva | 1 | 2012 | 10 | 0.100 |
Why?
| | Cohort Studies | 5 | 2021 | 5444 | 0.100 |
Why?
| | Artificial Intelligence | 3 | 2023 | 245 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 796 | 0.090 |
Why?
| | Heart Septum | 1 | 2011 | 27 | 0.090 |
Why?
| | Myocardial Ischemia | 1 | 2012 | 259 | 0.090 |
Why?
| | Asia | 2 | 2020 | 58 | 0.090 |
Why?
| | Nanoparticles | 1 | 2014 | 376 | 0.080 |
Why?
| | Latin America | 2 | 2020 | 87 | 0.080 |
Why?
| | Pressure | 1 | 2011 | 240 | 0.080 |
Why?
| | Pennsylvania | 1 | 2010 | 108 | 0.080 |
Why?
| | Telemetry | 1 | 2010 | 39 | 0.080 |
Why?
| | Brugada Syndrome | 1 | 2009 | 9 | 0.080 |
Why?
| | Genetic Diseases, Inborn | 1 | 2009 | 36 | 0.080 |
Why?
| | Heart Valve Diseases | 1 | 2011 | 152 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2511 | 0.080 |
Why?
| | Logistic Models | 2 | 2014 | 1989 | 0.080 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2011 | 177 | 0.070 |
Why?
| | Reference Values | 2 | 2010 | 796 | 0.070 |
Why?
| | Pharmacogenetics | 1 | 2009 | 172 | 0.070 |
Why?
| | Office Visits | 1 | 2008 | 87 | 0.070 |
Why?
| | Age Factors | 2 | 2018 | 3161 | 0.070 |
Why?
| | Sensitivity and Specificity | 3 | 2008 | 1847 | 0.070 |
Why?
| | Severity of Illness Index | 3 | 2018 | 2739 | 0.070 |
Why?
| | Comorbidity | 2 | 2017 | 1551 | 0.070 |
Why?
| | Blood Gas Analysis | 1 | 2007 | 73 | 0.070 |
Why?
| | Coronary Artery Disease | 1 | 2013 | 680 | 0.070 |
Why?
| | Miniaturization | 1 | 2006 | 23 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1199 | 0.070 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2021 | 144 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 2 | 2018 | 2271 | 0.060 |
Why?
| | Professional Competence | 1 | 2006 | 96 | 0.060 |
Why?
| | Pilot Projects | 2 | 2021 | 1597 | 0.060 |
Why?
| | Waist-Hip Ratio | 1 | 2005 | 35 | 0.060 |
Why?
| | Myocardial Contraction | 1 | 2007 | 335 | 0.060 |
Why?
| | Pattern Recognition, Automated | 1 | 2006 | 75 | 0.060 |
Why?
| | Aged, 80 and over | 4 | 2018 | 7066 | 0.060 |
Why?
| | Carotid Stenosis | 1 | 2006 | 84 | 0.060 |
Why?
| | Blood Pressure | 2 | 2017 | 1736 | 0.060 |
Why?
| | Ultrasonography, Doppler | 1 | 2005 | 118 | 0.060 |
Why?
| | Lipoproteins | 1 | 2005 | 172 | 0.060 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2024 | 72 | 0.060 |
Why?
| | Confidence Intervals | 1 | 2005 | 318 | 0.060 |
Why?
| | Anesthesia, Cardiac Procedures | 1 | 2024 | 6 | 0.060 |
Why?
| | Age Distribution | 1 | 2005 | 372 | 0.060 |
Why?
| | Sex Distribution | 1 | 2005 | 359 | 0.060 |
Why?
| | ROC Curve | 2 | 2018 | 504 | 0.060 |
Why?
| | Cardiologists | 1 | 2024 | 46 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2006 | 252 | 0.050 |
Why?
| | Physician-Patient Relations | 1 | 2008 | 542 | 0.050 |
Why?
| | Sternotomy | 1 | 2023 | 25 | 0.050 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2016 | 186 | 0.050 |
Why?
| | Triglycerides | 1 | 2005 | 528 | 0.050 |
Why?
| | Protamines | 1 | 2023 | 7 | 0.050 |
Why?
| | Linear Models | 1 | 2005 | 822 | 0.050 |
Why?
| | Diagnosis, Differential | 2 | 2020 | 1434 | 0.050 |
Why?
| | Adolescent | 5 | 2021 | 20451 | 0.050 |
Why?
| | Survival Analysis | 2 | 2018 | 1271 | 0.050 |
Why?
| | Mentors | 1 | 2024 | 177 | 0.050 |
Why?
| | Career Choice | 1 | 2024 | 206 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2005 | 1501 | 0.050 |
Why?
| | Sex Factors | 2 | 2018 | 1973 | 0.050 |
Why?
| | Chlorides | 1 | 2022 | 139 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2024 | 521 | 0.050 |
Why?
| | Atherosclerosis | 1 | 2006 | 402 | 0.050 |
Why?
| | Anesthesia | 1 | 2024 | 172 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 515 | 0.050 |
Why?
| | Tachycardia | 1 | 2021 | 57 | 0.050 |
Why?
| | Doxorubicin | 1 | 2023 | 329 | 0.050 |
Why?
| | Databases, Factual | 2 | 2018 | 1269 | 0.050 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2021 | 28 | 0.050 |
Why?
| | Factor Xa Inhibitors | 1 | 2023 | 170 | 0.050 |
Why?
| | Vagus Nerve | 1 | 2021 | 86 | 0.040 |
Why?
| | Psychometrics | 1 | 2024 | 701 | 0.040 |
Why?
| | Rivaroxaban | 1 | 2023 | 252 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 443 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2021 | 379 | 0.040 |
Why?
| | Warfarin | 1 | 2020 | 147 | 0.040 |
Why?
| | Young Adult | 4 | 2021 | 12467 | 0.040 |
Why?
| | Antithrombins | 1 | 2020 | 58 | 0.040 |
Why?
| | Operative Time | 1 | 2020 | 124 | 0.040 |
Why?
| | Tricuspid Valve | 1 | 2019 | 28 | 0.040 |
Why?
| | Practice Patterns, Physicians' | 1 | 2008 | 1274 | 0.040 |
Why?
| | Europe | 1 | 2020 | 363 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 302 | 0.040 |
Why?
| | Patient Participation | 1 | 2022 | 414 | 0.040 |
Why?
| | Sus scrofa | 1 | 2018 | 46 | 0.040 |
Why?
| | Disease Progression | 2 | 2019 | 2628 | 0.040 |
Why?
| | International Cooperation | 1 | 2019 | 177 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 234 | 0.040 |
Why?
| | Decision Trees | 1 | 2018 | 90 | 0.040 |
Why?
| | Electric Impedance | 1 | 2018 | 102 | 0.040 |
Why?
| | Hemorrhage | 1 | 2023 | 680 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2005 | 2724 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 97 | 0.040 |
Why?
| | Italy | 1 | 2017 | 99 | 0.030 |
Why?
| | Advisory Committees | 1 | 2019 | 216 | 0.030 |
Why?
| | Body Mass Index | 1 | 2005 | 2274 | 0.030 |
Why?
| | Prosthesis Fitting | 1 | 2016 | 16 | 0.030 |
Why?
| | Thermal Conductivity | 1 | 2016 | 5 | 0.030 |
Why?
| | Blood Glucose | 1 | 2005 | 2103 | 0.030 |
Why?
| | Decision Making | 1 | 2022 | 864 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2016 | 4077 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 376 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 192 | 0.030 |
Why?
| | Hospitals, Low-Volume | 1 | 2015 | 22 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 39 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 304 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2017 | 569 | 0.030 |
Why?
| | Internship and Residency | 1 | 2024 | 1058 | 0.030 |
Why?
| | Biomarkers | 1 | 2005 | 3971 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1500 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1406 | 0.030 |
Why?
| | Health Care Costs | 1 | 2017 | 367 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2015 | 122 | 0.030 |
Why?
| | Friction | 1 | 2013 | 14 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2012 | 3384 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5085 | 0.030 |
Why?
| | Czech Republic | 1 | 2013 | 3 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2015 | 165 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 716 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2017 | 852 | 0.030 |
Why?
| | Motion | 1 | 2013 | 98 | 0.030 |
Why?
| | Surface Properties | 1 | 2013 | 400 | 0.020 |
Why?
| | Algorithms | 2 | 2012 | 1617 | 0.020 |
Why?
| | Veins | 1 | 2012 | 60 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 2695 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2014 | 1201 | 0.020 |
Why?
| | Quality Improvement | 1 | 2019 | 1112 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 220 | 0.020 |
Why?
| | Angiography | 1 | 2011 | 197 | 0.020 |
Why?
| | Coronary Angiography | 1 | 2012 | 306 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 3706 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3062 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1291 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1724 | 0.020 |
Why?
| | Patient Readmission | 1 | 2014 | 668 | 0.020 |
Why?
| | Wisconsin | 1 | 2008 | 99 | 0.020 |
Why?
| | Physicians' Offices | 1 | 2006 | 17 | 0.020 |
Why?
| | Observer Variation | 1 | 2006 | 314 | 0.010 |
Why?
| | Image Enhancement | 1 | 2006 | 168 | 0.010 |
Why?
| | Motivation | 1 | 2008 | 548 | 0.010 |
Why?
| | Population Surveillance | 1 | 2006 | 439 | 0.010 |
Why?
| | Health Behavior | 1 | 2008 | 743 | 0.010 |
Why?
| | Family Practice | 1 | 2006 | 456 | 0.010 |
Why?
| | Child | 1 | 2021 | 20962 | 0.010 |
Why?
|
|
Tzou's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|